Robert L Fleshman, a director at $IVR, sold 2,000 shares of the company on 11-10-2025 for an estimated $49,444. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $IVR stock.
$IVR Insider Trading Activity
$IVR insiders have traded $IVR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IVR stock by insiders over the last 6 months:
- ROBERT L FLESHMAN sold 2,000 shares for an estimated $49,444
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IVR Hedge Fund Activity
We have seen 84 institutional investors add shares of $IVR stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. removed 1,949,391 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $15,283,225
- TWO SIGMA INVESTMENTS, LP removed 352,843 shares (-36.5%) from their portfolio in Q2 2025, for an estimated $2,766,289
- UBS GROUP AG removed 256,628 shares (-31.0%) from their portfolio in Q2 2025, for an estimated $2,011,963
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 239,301 shares (+337.2%) to their portfolio in Q2 2025, for an estimated $1,876,119
- STATE STREET CORP added 230,927 shares (+20.6%) to their portfolio in Q2 2025, for an estimated $1,810,467
- WOLVERINE ASSET MANAGEMENT LLC added 226,411 shares (+23.5%) to their portfolio in Q3 2025, for an estimated $1,711,667
- ZACKS INVESTMENT MANAGEMENT added 205,845 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,613,824
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
